Biotech Values

[DewDiligence]

NVO’s Investor Day webcast corroborated the contention of other pharma companies (e.g. #msg-59590951, bottom) that operating margins in emerging markets are at least as high as they are in developed markets. This is a point that I think many investors continue to overlook.